Skip to main content
. 2019 Mar 29;24(2):348–358. doi: 10.1177/1087054719836159

Figure 2.

Figure 2.

Subject disposition.

Note. ITT = intention-to-treat; PP = per-protocol.

aOne participant randomized to SPN-812 300 mg/day received 100 mg/day throughout the study; this participant is included in the 100 mg/day group in all safety analyses, but in the 300 mg/day group in all analyses based on the ITT population.